Core Insights - The tobacco sector in 2025 presents two main investment options: Altria Group, Inc. and Philip Morris International Inc., each with distinct strategies and market focuses [1][2] Philip Morris Overview - Philip Morris is leading the transition to reduced-risk products (RRPs) with its flagship product IQOS, which has gained significant traction in international markets, contributing to volume growth and solidifying its leadership in the global RRP segment [3][4] - The acquisition of Swedish Match in 2022 expanded Philip Morris's smoke-free portfolio, with smoke-free products accounting for 42% of total revenues and 44% of gross profit in Q1 2025, reflecting a 15% year-over-year revenue growth in this segment [4][5] - Despite a focus on RRPs, Philip Morris also reported a 3.8% organic revenue growth in its traditional tobacco segment, demonstrating a balanced strategy between legacy products and innovation [5] Altria Overview - Altria has shown resilience against declining cigarette volumes through strong pricing power, with projected adjusted earnings per share for 2025 ranging from $5.30 to $5.45, indicating up to 5% year-over-year growth [10][12] - The company is making progress in the smoke-free market with its on! nicotine pouch product, which saw an 18% year-over-year shipment growth in Q1 2025, capturing significant market share despite higher retail prices [11] - Altria's recent acquisition of NJOY aims to strengthen its position in the e-vapor category, with plans for a relaunch focused on regulatory compliance and product quality [12][13] Valuation and Performance Comparison - Philip Morris trades at a forward P/E of 22.76x, reflecting a premium valuation due to its global presence and smoke-free momentum, while Altria trades at a lower multiple of 10.79x, appealing to value-focused investors [15] - Over the past year, Philip Morris has achieved a 76.1% stock gain, significantly outperforming Altria's 27.1% and the S&P 500's 10.8% return, indicating strong investor confidence in Philip Morris [17] Investor Considerations - Philip Morris is recognized for its leadership in RRPs and innovation, but its success may be largely priced in, with potential regulatory and currency risks [18] - Altria, while facing challenges in cigarette volumes, presents a compelling value proposition with lower valuation metrics and growth potential in smoke-free products and the vapor category [18]
MO or PM: Which Tobacco Giant Offers Better Value in 2025?